Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 04 May 2017 | By Zachary Brennan
With ongoing work on guidance related to software as a medical device, and a new dedicated unit to digital health coming to the US Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), the agency is slowly but surely dipping its toe into the rapidly advancing field.
Bakul Patel, associate center director for digital health at FDA, told attendees at MedCon in Cincinnati on Thursday that current work is directed at funneling through about 1,400 comments on draft guidance on software as a medical device released last October, which is also a priority for the International Medical Device Regulators Forum (IMDRF).
Patel noted that FDA is currently working on "what clinical validation looks like for software," adding that the 46-page document will likely be simplified to 20 pages when finalized.
A lot of the debate from the comments centered around how to define scientific and clinical validation, Patel said, noting the incredibly rapid lifecycle of software programs and the difficulty of regulating them.
And in terms of FDA’s new digital health unit, which will be established within CDRH’s Office of the Center Director thanks to the next iteration of the Medical Device User Fee Amendments, Patel noted that the unit will need cross-coordination and will explore opportunities to establish premarket approval and/or clearance pathways tailored for digital health that take into account real world evidence.
"How do we credit people who are doing the right things?" Patel said.
He also noted that some of the language in the recently passed 21st Century Cures Act "put a wrinkle in our plans" to tackle digital health and forced the agency to take a step back. However, he acknowledged that FDA will release some discussion of the Cures legislation.
"As we go forward, it shouldn’t stop you folks from going forward," he told medical device industry leaders at the conference.
Other topics that FDA’s digital health unit will devote time and resources to include artificial intelligence, advanced analytics, the cloud, wireless medical devices, telemedicine, interoperability, health IT and cybersecurity.
Tags: digital health, software as a medical device, cybersecurity
Regulatory Focus newsletters
All the biggest regulatory news and happenings.